A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABBV-903;   Drug: Placebo for ABBV-903 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children Phase III Clinical Trial
Conditions:   Lesion in Body Region;   CNS Lesion Interventions:   Drug: Gadopiclenol;   Drug: Comparator Sponsors:   Guerbet;   Bracco Imaging S.p.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABBV-903;   Drug: Placebo for ABBV-903 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children Phase III Clinical Trial
Conditions:   Lesion in Body Region;   CNS Lesion Interventions:   Drug: Gadopiclenol;   Drug: Comparator Sponsors:   Guerbet;   Bracco Imaging S.p.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABBV-903;   Drug: Placebo for ABBV-903 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children Phase III Clinical Trial
Conditions:   Lesion in Body Region;   CNS Lesion Interventions:   Drug: Gadopiclenol;   Drug: Comparator Sponsors:   Guerbet;   Bracco Imaging S.p.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABBV-903;   Drug: Placebo for ABBV-903 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children Phase III Clinical Trial
Conditions:   Lesion in Body Region;   CNS Lesion Interventions:   Drug: Gadopiclenol;   Drug: Comparator Sponsors:   Guerbet;   Bracco Imaging S.p.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABBV-903;   Drug: Placebo for ABBV-903 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children Phase III Clinical Trial
Conditions:   Lesion in Body Region;   CNS Lesion Interventions:   Drug: Gadopiclenol;   Drug: Comparator Sponsors:   Guerbet;   Bracco Imaging S.p.A. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABBV-903;   Drug: Placebo for ABBV-903 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants
Condition:   Gastroenteritis Interventions:   Biological: Placebo;   Biological: HIL-214 Sponsor:   HilleVax Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials